Elmind Capital, LP

Elmind Capital, LP reported 30 holdings worth US$404M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Elmind Capital, LP reported 30 holdings worth US$404M as of Sep 30, 2026. Largest: Celldex Therapeutics, Inc., Legend Biotech Corp. and Syndax Pharmaceuticals, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
30
Value as reported
US$404M

The filing in full

CompanySharesValue as reported% of portfolio
Celldex Therapeutics, Inc.1.11MUS$36M8.9%
Legend Biotech Corp.1.57MUS$31.2M7.7%
Syndax Pharmaceuticals, Inc.1.6MUS$30.2M7.5%
Cogent Biosciences, Inc.867KUS$27.8M6.9%
Relay Therapeutics, Inc.1.47MUS$26.4M6.5%
Amylyx Pharmaceuticals, Inc.895KUS$26M6.4%
Viridian Therapeutics, Inc.1.22MUS$25.2M6.2%
Vaxcyte, Inc.372KUS$21.2M5.2%
Travere Therapeutics, Inc.323KUS$19M4.7%
Cullinan Therapeutics, Inc.963KUS$14.8M3.7%
Vera Therapeutics, Inc.437KUS$14.1M3.5%
CytomX Therapeutics, Inc.4.55MUS$12.4M3.1%
Beam Therapeutics Inc.476KUS$11.6M2.9%
Nurix Therapeutics, Inc.460KUS$10.9M2.7%
Summit Therapeutics Inc.494KUS$8.35M2.1%
United Therapeutics Corporation15,000US$8.13M2.0%
Immunocore Holdings plc256KUS$7.76M1.9%
Krystal Biotech, Inc.22,000US$7.32M1.8%
Alumis Inc.750KUS$5.54M1.4%
BioCryst Pharmaceuticals, Inc.520KUS$4.33M1.1%
Sutro Biopharma, Inc.228KUS$3.68M0.91%
MBX Biosciences, Inc.61,000US$3.58M0.89%
DBV Technologies SA265KUS$3.12M0.77%
Supernus Pharmaceuticals, Inc.70,000US$3.01M0.75%
BioMarin Pharmaceutical Inc.47,000US$2.82M0.70%
Septerna, Inc.49,444US$1.93M0.48%
Alector, Inc.916KUS$1.69M0.42%
Design Therapeutics, Inc.108KUS$1.36M0.34%
Insmed Incorporated0US$00.00%
Protagonist Therapeutics, Inc.0US$00.00%
Tyra Biosciences, Inc.0US$00.00%

Source

Download original · View original at SEC

Related